ATE106734T1 - Pharmazeutische zusammensetzung zur verhinderung der plättchenaggregation. - Google Patents

Pharmazeutische zusammensetzung zur verhinderung der plättchenaggregation.

Info

Publication number
ATE106734T1
ATE106734T1 AT91307773T AT91307773T ATE106734T1 AT E106734 T1 ATE106734 T1 AT E106734T1 AT 91307773 T AT91307773 T AT 91307773T AT 91307773 T AT91307773 T AT 91307773T AT E106734 T1 ATE106734 T1 AT E106734T1
Authority
AT
Austria
Prior art keywords
pharmaceutical composition
platelet aggregation
alkyl group
lower alkyl
prevent platelet
Prior art date
Application number
AT91307773T
Other languages
English (en)
Inventor
Akio Odawara
Yasuhiko Sasaki
Sakae Murata
Hiroshi Narita
Original Assignee
Tanabe Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2243729A external-priority patent/JPH078799B2/ja
Priority claimed from JP2243728A external-priority patent/JPH078798B2/ja
Application filed by Tanabe Seiyaku Co filed Critical Tanabe Seiyaku Co
Application granted granted Critical
Publication of ATE106734T1 publication Critical patent/ATE106734T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT91307773T 1990-09-17 1991-08-23 Pharmazeutische zusammensetzung zur verhinderung der plättchenaggregation. ATE106734T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2243729A JPH078799B2 (ja) 1990-09-17 1990-09-17 血小板凝集抑制組成物
JP2243728A JPH078798B2 (ja) 1990-09-17 1990-09-17 血小板凝集抑制組成物

Publications (1)

Publication Number Publication Date
ATE106734T1 true ATE106734T1 (de) 1994-06-15

Family

ID=26536403

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91307773T ATE106734T1 (de) 1990-09-17 1991-08-23 Pharmazeutische zusammensetzung zur verhinderung der plättchenaggregation.

Country Status (9)

Country Link
US (1) US5387581A (de)
EP (1) EP0476854B1 (de)
KR (1) KR0145689B1 (de)
AT (1) ATE106734T1 (de)
CA (1) CA2049655C (de)
DE (1) DE69102379T2 (de)
DK (1) DK0476854T3 (de)
ES (1) ES2057777T3 (de)
FR (1) FR2666741B1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5637582A (en) * 1992-10-23 1997-06-10 Tanabe Seiyaku Co., Ltd. Peripheral circulation improving agent
DE69313775T2 (de) * 1992-10-23 1998-01-22 Tanabe Seiyaku Co Mittel zur Verbesserung der peripheren Durchblutung
US20030235587A1 (en) * 1998-08-07 2003-12-25 Feuerstein Giora Z. Anticoagulant agents useful in treatment of thrombosis
MA24512A1 (fr) 1996-01-17 1998-12-31 Univ Vermont And State Agrienl Procede pour la preparation d'agents anticoagulants utiles dans le traitement de la thrombose
US20070190059A1 (en) * 1996-01-17 2007-08-16 Smithkline Beecham Corporation Antithrombotic agents
US6010911A (en) * 1997-04-30 2000-01-04 Medtronic, Inc. Apparatus for performing a heparin-independent high sensitivity platelet function evaluation technique
KR20070116192A (ko) * 2000-05-15 2007-12-06 스미스클라인 비참 코포레이션 항혈전제
WO2005116623A2 (en) 2004-05-17 2005-12-08 Medtronic, Inc. Point of care heparin determination system

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4567175A (en) * 1983-06-03 1986-01-28 Tanabe Seiyaku Co., Ltd. 8-Chloro-1,5-benzothiazepine derivatives
US4590188A (en) * 1984-02-18 1986-05-20 Tanabe Seiyaku Co., Ltd. 1,5-benzothiazepine derivatives and their pharmaceutical use
US4594342A (en) * 1984-04-10 1986-06-10 Tanabe Seiyaku Co., Ltd. 1,5-benzothiazepine derivative
FR2589358B1 (fr) * 1985-07-30 1987-12-04 Synthelabo Compositions pharmaceutiques a base de diltiazem et d'aspirine
DE3626097A1 (de) * 1986-07-31 1988-02-11 Goedecke Ag Wirkstoffkombination enthaltend diltiazem und acetylsalicylsaeure

Also Published As

Publication number Publication date
US5387581A (en) 1995-02-07
CA2049655C (en) 1996-11-12
ES2057777T3 (es) 1994-10-16
DE69102379D1 (de) 1994-07-14
FR2666741A1 (fr) 1992-03-20
DE69102379T2 (de) 1994-09-29
KR0145689B1 (ko) 1998-08-17
CA2049655A1 (en) 1992-03-18
EP0476854A1 (de) 1992-03-25
KR920005986A (ko) 1992-04-27
DK0476854T3 (da) 1994-07-11
FR2666741B1 (fr) 1993-01-08
EP0476854B1 (de) 1994-06-08

Similar Documents

Publication Publication Date Title
NZ214156A (en) Quindone derivatives and pharmaceutical compositions
ZA89389B (en) Use of 1,4-disubstituted-piperidinyl compounds in the manufacture of a medicament for the treatment of insomnia
ATE106734T1 (de) Pharmazeutische zusammensetzung zur verhinderung der plättchenaggregation.
ES2055235T3 (es) Composicion anti-inflamatoria y/o antialergica que comprende derivados de glutation.
DE69302035D1 (de) Pharmazeutische Zusammensetzung zur Hemmung der Thrombocytenaggregation
DE69001004D1 (de) Zusammensetzung gegen leberkrankheiten.
AU584988B2 (en) New 8-thiotetrahydroquinoline derivatives and salts thereof
SE8901060D0 (sv) New compounds
DE69219219D1 (de) Verwendung von 3-Pyridazinone zur Verringerung der Blutplätchenzahl
DE69226443D1 (de) N-(mercaptoacyl)aminosäure, ihre herstellung, ihre therapeutische verwendung und sie enthaltende pharmazeutische zusammensetzungen
IL87107A0 (en) Naphthothiazepine derivatives,their preparation and pharmaceutical compositions containing them
AU5920486A (en) 6,9-epoxy-7-fluoro-11-hydroxy-prost-5-en-1-oic acid derivatives
ATE67197T1 (de) Thiadiazinon-derivate.
DE3782229D1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee